In vitro diagnostics may be a suite of diagnostic tests performed using analytical instruments and reagents, on samples like blood, stools, urine, tissues, and other body fluids. These samples are derived from patients or healthy individuals, to detect diseases or infections. a number of the many technologies incorporated in in vitro diagnostics are polymerase chain reaction, immunoassays, and sequencing technologies. In vitro diagnostics play significant role in risk assessment, and disease monitoring. Great advances are achieved lately, particularly within the field of clinical immunology Recombinant allergens are investigated in diagnosing asthma and food, pollen-induced and bug allergies, in in vitro testing.The in-vitro diagnostic market is predicted to witness robust growth within the coming years, on account of the rising incidence of infectious diseases, requirement for early disease diagnosis, rapid automation of testing laboratories, usage of point-of-care testing, and recognition of personalized medicine. Instruments, reagents and kits, services, and data management software/hardware are the varied products and services available within the industry. Within the period, the most important size within the industry was accounted for by reagents and kits. Immunochemistry, clinical chemistry, coagulation and hemostasis, microbiology, molecular diagnostics, hematology, and a number of other technologies are leveraged for such medical evaluation. Historically, immunochemistry has held the most important in-vitro diagnostic market share, on account of its faster and more-accurate results, which increase its preference over other techniques for medical testing.
Medical testing finds application in autoimmune diseases, diabetes, infectious diseases, cardiology, nephrology, oncology, human immunodeficiency virus (HIV), and drug testing.The global In Vitro Diagnostics market is segregated on the basis of Application as Autoimmune Diseases, Nephrology, Drug Testing/Pharmacogenomics, HIV/Aids, Infectious Diseases, Diabetes, Oncology, Cardiology, and Other Applications. Based on End User the global In Vitro Diagnostics market is segmented in Point-Of-Care Testing, Patient Self-Testing, Hospitals, Academic Institutes, Other End Users, and Laboratories. Based on Product & Service the global In Vitro Diagnostics market is segmented in Reagents & Kits, Data Management Software, Services, and Instruments.
Based on Technology, the global In Vitro Diagnostics market is segmented in Coagulation and Hemostasis, Urinalysis, Microbiology, Hematology, Other IVD Technologies, Clinical Chemistry, Molecular Diagnostics, and Immunoassay/Immunochemistry.
The global In Vitro Diagnostics market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The In Vitro Diagnostics market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Quidel Corporation, Orasure Technologies, Inc., Stago, Hologic, Inc., Ortho Clinical Diagnostics, Roche Diagnostics, Danaher Corporation, Abbott Laboratories, Inc., Siemens AG, Sysmex Corporation, and others are among the major players in the global In Vitro Diagnostics market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The In Vitro Diagnostics Market has been segmented as below:
In Vitro Diagnostics Market, By Application
In Vitro Diagnostics Market, By End User
In Vitro Diagnostics Market, By Product & Service
In Vitro Diagnostics Market, By Technology
In Vitro Diagnostics Market, By Region
In Vitro Diagnostics Market, By Company
The report covers:
Report Scope:
The global In Vitro Diagnostics market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global In Vitro Diagnostics market share. Major industry players with significant revenue share include Quidel Corporation, Orasure Technologies, Inc., Stago, Hologic, Inc., Ortho Clinical Diagnostics, Roche Diagnostics, Danaher Corporation, Abbott Laboratories, Inc., Siemens AG, Sysmex Corporation, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations.
Below are our New Reports :-
Clinical Immunochemistry Analyzers Market
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. In Vitro Diagnostics Market, By Application
5.1 Introduction
5.2 Autoimmune Diseases
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Nephrology
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Drug Testing/Pharmacogenomics
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 HIV/Aids
5.5.1 Market Overview
5.5.2 Market Size and Forecast
5.6 Infectious Diseases
5.6.1 Market Overview
5.6.2 Market Size and Forecast
5.7 Diabetes
5.7.1 Market Overview
5.7.2 Market Size and Forecast
5.8 Oncology
5.8.1 Market Overview
5.8.2 Market Size and Forecast
5.9 Cardiology
5.9.1 Market Overview
5.9.2 Market Size and Forecast
5.10 Other Applications
5.10.1 Market Overview
5.10.2 Market Size and Forecast
6. In Vitro Diagnostics Market, By End User
6.1 Introduction
6.2 Point-Of-Care Testing
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Patient Self-Testing
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Hospitals
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Academic Institutes
6.5.1 Market Overview
6.5.2 Market Size and Forecast
6.6 Other End Users
6.6.1 Market Overview
6.6.2 Market Size and Forecast
6.7 Laboratories
6.7.1 Market Overview
6.7.2 Market Size and Forecast
7. In Vitro Diagnostics Market, By Product & Service
7.1 Introduction
7.2 Reagents & Kits
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Data Management Software
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Services
7.4.1 Market Overview
7.4.2 Market Size and Forecast
7.5 Instruments
7.5.1 Market Overview
7.5.2 Market Size and Forecast
8. In Vitro Diagnostics Market, By Technology
8.1 Introduction
8.2 Coagulation and Hemostasis
8.2.1 Market Overview
8.2.2 Market Size and Forecast
8.3 Urinalysis
8.3.1 Market Overview
8.3.2 Market Size and Forecast
8.4 Microbiology
8.4.1 Market Overview
8.4.2 Market Size and Forecast
8.5 Hematology
8.5.1 Market Overview
8.5.2 Market Size and Forecast
8.6 Other IVD Technologies
8.6.1 Market Overview
8.6.2 Market Size and Forecast
8.7 Clinical Chemistry
8.7.1 Market Overview
8.7.2 Market Size and Forecast
8.8 Molecular Diagnostics
8.8.1 Market Overview
8.8.2 Market Size and Forecast
8.9 Immunoassay/Immunochemistry
8.9.1 Market Overview
8.9.2 Market Size and Forecast
9. In Vitro Diagnostics Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 North America In Vitro Diagnostics, By Application
9.2.2 North America In Vitro Diagnostics, By End User
9.2.3 North America In Vitro Diagnostics, By Product & Service
9.2.4 North America In Vitro Diagnostics, By Technology
9.3 Europe
9.3.1 Europe In Vitro Diagnostics, By Application
9.3.2 Europe In Vitro Diagnostics, By End User
9.3.3 Europe In Vitro Diagnostics, By Product & Service
9.3.4 Europe In Vitro Diagnostics, By Technology
9.4 Asia-Pacific
9.4.1 Asia-Pacific In Vitro Diagnostics, By Application
9.4.2 Asia-Pacific In Vitro Diagnostics, By End User
9.4.3 Asia-Pacific In Vitro Diagnostics, By Product & Service
9.4.4 Asia-Pacific In Vitro Diagnostics, By Technology
9.5 Rest of the World
9.5.1 Rest of the World In Vitro Diagnostics, By Application
9.5.2 Rest of the World In Vitro Diagnostics, By End User
9.5.3 Rest of the World In Vitro Diagnostics, By Product & Service
9.5.4 Rest of the World In Vitro Diagnostics, By Technology
10. Competitive Insights
10.1 Key Insights
10.2 Company Market Share Analysis
10.3 Strategic Outlook
10.3.1 Mergers & Acquisitions
10.3.2 New Product Development
10.3.3 Portfolio/Production Capacity Expansions
10.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
10.3.5 Others
11. Company Profiles
11.1 Quidel Corporation
11.1.1 Company Overview
11.1.2 Product/Service Landscape
11.1.3 Financial Overview
11.1.4 Recent Developments
11.2 Orasure Technologies, Inc.
11.2.1 Company Overview
11.2.2 Product/Service Landscape
11.2.3 Financial Overview
11.2.4 Recent Developments
11.3 Stago
11.3.1 Company Overview
11.3.2 Product/Service Landscape
11.3.3 Financial Overview
11.3.4 Recent Developments
11.4 Hologic, Inc.
11.4.1 Company Overview
11.4.2 Product/Service Landscape
11.4.3 Financial Overview
11.4.4 Recent Developments
11.5 Ortho Clinical Diagnostics
11.5.1 Company Overview
11.5.2 Product/Service Landscape
11.5.3 Financial Overview
11.5.4 Recent Developments
11.6 Roche Diagnostics
11.6.1 Company Overview
11.6.2 Product/Service Landscape
11.6.3 Financial Overview
11.6.4 Recent Developments
11.7 Danaher Corporation
11.7.1 Company Overview
11.7.2 Product/Service Landscape
11.7.3 Financial Overview
11.7.4 Recent Developments
11.8 Abbott Laboratories, Inc.
11.8.1 Company Overview
11.8.2 Product/Service Landscape
11.8.3 Financial Overview
11.8.4 Recent Developments
11.9 Siemens AG
11.9.1 Company Overview
11.9.2 Product/Service Landscape
11.9.3 Financial Overview
11.9.4 Recent Developments
11.10 Sysmex Corporation
11.10.1 Company Overview
11.10.2 Product/Service Landscape
11.10.3 Financial Overview
11.10.4 Recent Developments
10.11 Thermo Fisher Scientific
11.11.1 Company Overview
11.11.2 Product/Service Landscape
11.11.3 Financial Overview
11.11.4 Recent Developments
10.12 Becton, Dickinson and Company
11.12.1 Company Overview
11.12.2 Product/Service Landscape
11.12.3 Financial Overview
11.12.4 Recent Developments
10.13 Biomérieux Sa
11.13.1 Company Overview
11.13.2 Product/Service Landscape
11.13.3 Financial Overview
11.13.4 Recent Developments
10.14 Bio-Rad Laboratories, Inc.
11.14.1 Company Overview
11.14.2 Product/Service Landscape
11.14.3 Financial Overview
11.14.4 Recent Developments
10.15 Johnson & Johnson
11.15.1 Company Overview
11.15.2 Product/Service Landscape
11.15.3 Financial Overview
11.15.4 Recent Developments
10.16 Agilent Technologies
11.16.1 Company Overview
11.16.2 Product/Service Landscape
11.16.3 Financial Overview
11.16.4 Recent Developments
10.17 Qiagen
11.17.1 Company Overview
11.17.2 Product/Service Landscape
11.17.3 Financial Overview
11.17.4 Recent Developments
10.18 Diasorin
11.18.1 Company Overview
11.18.2 Product/Service Landscape
11.18.3 Financial Overview
11.18.4 Recent Developments
10.19 Leica Biosystems Nussloch GmbH
11.19.1 Company Overview
11.19.2 Product/Service Landscape
11.19.3 Financial Overview
11.19.4 Recent Developments
10.20 Cepheid
11.20.1 Company Overview
11.20.2 Product/Service Landscape
11.20.3 Financial Overview
11.20.4 Recent Developments
The In Vitro Diagnostics Market has been segmented as below:
In Vitro Diagnostics Market, By Application
In Vitro Diagnostics Market, By End User
In Vitro Diagnostics Market, By Product & Service
In Vitro Diagnostics Market, By Technology
In Vitro Diagnostics Market, By Region
In Vitro Diagnostics Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
